Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 30, 2025
miRecule and GBI Biomanufacturing announced a strategic partnership to advance the development and clinical supply of miRecule's innovative Antibody-RNA Conjugate (ARC) based products.
read more
Mispro Biotech Services announced expansion of its network of vivarium research facilities with the opening of an 18,000-square-foot facility in Broad Hollow Bioscience Park in Farmingdale, NY.
read more
Mission has raised $15m in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer.
read more
Thursday, September 13, 2018
Mitra Biotech announced a partnership with Glenmark Pharmaceuticals focused on advancing Glenmark's proprietary immuno-oncology drug pipeline utilizing Mitra's CANscript platform.
read more
Certara®, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Mitsubishi Tanabe has joined its Simcyp Consortium and licensed its proprietary Simcyp® ...
read more
Tuesday, November 21, 2017
Mitsubishi Tanabe Pharma America announced the appointment of Kevin O'Brien as Vice President of Market Access and a member of the organization's executive leadership team.
read more
Monday, November 20, 2017
Mitsui Chemicals announced the development of XSP series of Chemipearl which is a high performance “Water-based Heat Seal Coating” for pharmaceutical blister packaging.
read more
Wednesday, August 30, 2017
MMIS announced that it will partner with LexisNexis Risk Solutions to bring LexisNexis Expense Manager software into the MediSpend Compliance Cloud.
read more
Avista Pharma announced MMRF has contracted the company to manufacture an opioid-derived small molecule, a key component of a conjugate vaccine in development to treat opioid addiction.
read more
Tuesday, February 10, 2026
MMS, a global, data-focused clinical research organization (CRO), announced that Somya Dunn, MD, has joined the company as Senior Medical Director, Safety Risk Management, further advancing the company’s leadership in risk-benefit assessments for ...
read more
MMS Holdings announced the addition of Dr. Mike Poole, MD, FACP to its board of scientific advisors.
read more
MMS Holdings has joined an alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
read more
Thursday, October 11, 2018
MMS announced their support to Paratek for the NDA approval and successful MAA filing of Nuzyra for the treatment of adults with CABP and ABSSSI.
read more
Tuesday, November 03, 2015
Moberg Pharma AB has announced that Moberg Pharma and Colep have entered a Development Agreement for MOB-015 – a novel topical formulation of terbinafine for onychomycosis (nail fungus).
read more
Mobidiag has signed an agreement with Ginolis, knowledgeable in assembly automation and high precision liquid handling solutions.
read more